Astragalus membranaceus Has Potential Anti-Aging and Anticancer Effects on Skin and Bone
Open Access
- 12 June 2026
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 16 (6) , 864
Abstract
Astragalus membranaceus, a medicinal plant used in traditional Chinese medicine for centuries, has attracted growing scientific attention for its potential anti-aging and anticancer properties, particularly for skin and bone health. Its key bioactive compounds like astragalosides, cycloastragenol, and its commercial derivative TA-65, have been associated with telomerase activation and telomere maintenance, suggesting a possible role in modulating cellular senescence and tissue repair processes. In addition to the claimed telomere maintenance, A. membranaceus exhibits antioxidant, anti-inflammatory, and DNA-protective activities, properties that contribute to its anti-aging effects. Emerging evidence also suggests that telomerase modulation by A. membranaceus influences cancer cell dynamics, either suppressing tumor progression through immune regulation and apoptosis induction or, in some contexts, potentially promoting tumor growth. This duality highlights the importance of dose, formulation, and targeted application. Clinically, TA-65 has been reported to improve vascular health, bone mineral density, and skin elasticity in aging individuals. Preclinical studies further support its protective effects against osteoporotic bone loss and photoaging-induced dermal degeneration. This review summarizes the phytochemical composition of A. membranaceus and critically evaluates the mechanistic and therapeutic evidence underlying its anti-aging and anticancer actions on skin and bone tissues. It also discusses the pharmacokinetic properties of A. membranaceus, including its absorption, bioavailability, and safety profile. The integration of A. membranaceus into evidence-based senile therapeutic strategies holds promise, but further mechanistic and clinical studies are required to optimize its safety and efficacy.Keywords
This publication has 63 references indexed in Scilit:
- Effects of TA-65 on telomere length, functional outcomes, and inflammation: a systematic review and meta-analysisCell Biology and Toxicology, 2025
- A pilot study on the efficacy of a telomerase activator in regulating the proliferation of A375 skin cancer cell lineMolecular Biology Reports, 2024
- Activation of telomerase by TA-65 enhances immunity and reduces inflammation post myocardial infarctionGeroScience, 2023
- Pharmacokinetics Comparison, Intestinal Absorption and Acute Toxicity Assessment of a Novel Water-Soluble Astragaloside IV Derivative (Astragalosidic Acid, LS-102)European Journal of Drug Metabolism and Pharmacokinetics, 2018
- Review of the Botanical Characteristics, Phytochemistry, and Pharmacology of Astragalus membranaceus (Huangqi)Phytotherapy Research, 2014
- Effects of Astragalus membranaceus with Supplemental Calcium on Bone Mineral Density and Bone Metabolism in Calcium-Deficient Ovariectomized RatsBiological Trace Element Research, 2012
- Protective effect of astragaloside IV against matrix metalloproteinase-1 expression in ultraviolet-irradiated human dermal fibroblastsArchives of Pharmacal Research, 2011
- Pharmacokinetics of astragalosideiv in beagle dogsEuropean Journal of Drug Metabolism and Pharmacokinetics, 2007
- Pharmacokinetics of Astragaloside IV in rats by liquid chromatography coupled with tandem mass spectrometryEuropean Journal of Drug Metabolism and Pharmacokinetics, 2005
- A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herbBiochemical and Biophysical Research Communications, 2004